Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Increased p53 transcription prior to DNA synthesis is regulated through a novel regulatory element within the p53 promoter

Oncogene volume 25, pages 555–565 (2006)Cite this article

Abstract

p53 mRNA levels are tightly regulated during the cell cycle with its transcription being induced prior to DNA synthesis. However, the mechanism controlling this regulation is not well defined. Through characterizing an additional 1000 bp of upstream DNA sequences of the murine p53 gene, we identified new positive and negative regulatory elements. Furthermore, we found a trans-acting factor(s) that binds within a positive cis-acting element (−972/−953) in a manner indicative of regulation during the cell cycle. When Swiss3T3 cells are arrested by serum depletion p53 mRNA levels decrease and binding of this regulatory factor(s) to the promoter is reduced. Upon serum stimulation, the regulatory factor(s) binds the promoter and p53 mRNA levels increase prior to the cells entering S phase. When the factors are experimentally sequestered from the promoter or when the regulatory element is deleted from the promoter, p53 promoter activity is reduced. There is no further reduction in p53 promoter activity upon serum depletion and the kinetics of induction upon serum stimulation is delayed by approximately 5 h. These findings indicate that a factor(s) binding within the −972/−953 regulatory element on the p53 promoter is important for the proper regulation of p53 mRNA expression in response to mitogen stimulation. Our initial findings indicate that a member of the C/EBP family of transcription factors may play a role in this regulation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Arnett B, Soisson P, Ducatman BS, Zhang P . (2003). Mol Cancer 2: 21.

  • Balint E, Reisman D . (1996). Cancer Res 56: 1648–1653.

  • Carey M . (1998). Cell 92: 5–8.

  • Choi J, Donehower LA . (1999). Cell Mol Life Sci 55: 38–47.

  • Eaton EM, Hanlon M, Bundy L, Sealy L . (2001). J Cell Physiol 189: 91–105.

  • El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM et al. (1993). Cell 75: 817–825.

  • Freedman DA, Levine AJ . (1999). Cancer Res 59: 1–7.

  • Giannakakou P, Sackett DL, Ward Y, Webster KR, Blagosklonny MV, Fojo T . (2000). Nat Cell Biol 2: 709–717.

  • Ginsberg D, Oren M, Yaniv M, Piette J . (1990). Oncogene 5: 1285–1290.

  • Gu W, Roeder RG . (1997). Cell 90: 595–606.

  • Hale TK, Braithwaite AW . (1995). Nucleic Acids Res 23: 663–669.

  • Hanlon M, Sealy L . (1999). J Biol Chem 274: 14224–14228.

  • Kubbutat MHG, Jones SN, Vousden KH . (1997). Nature 387: 299–303.

  • Kubbutat MHG, Vousden KH . (1998). Mol Med Today 4: 250–256.

  • Lang GA, Iwakuma T, Suh YA, Liu G, Rao VA, Parant JM et al. (2004). Cell 119: 861–872.

  • Lasham A, Moloney S, Hale T, Homer C, Zhang YF, Murison JG et al. (2003). J Biol Chem 278: 35516–35523.

  • Liu G, McDonnell TJ, Montes de Oca Luna R, Kapoor M, Mims B, El-Naggar AK et al. (2000). Proc Natl Acad Sci USA 97: 4174–4179.

  • Liu L, Scolnick DM, Trievel RC, Zhang HB, Marmorstein R, Halazonetis TD et al. (1999). Mol Cell Biol 19: 1202–1209.

  • McKnight SL . (2001). Cell 107: 259–261.

  • Mendrysa S, Perry ME . (2000). Mol Cell Biol 20: 2023–2030.

  • Milde-Langosch K, Loning T, Bamberger AM . (2003). Breast Cancer Res. Treat 79: 175–185.

  • Miyashita T, Reed JC . (1995). Cell 80: 293–299.

  • Miyazawa K, Mori A, Yamamoto K, Okudaira O . (1998). J Biol Chem 273: 7620–7627.

  • Mosner J, Mummenbrauer T, Bauer C, Sczakiel G, Grosse F, Deppert W . (1995). EMBO J 14: 4442–4449.

  • Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T et al. (2000). Cell 102: 849–862.

  • Olive KP, Tuveson DA, Ruhe ZC, Yin B, Willis NA, Bronson RT et al. (2004). Cell 119: 847–860.

  • Plaisance S, Berghe WV, Boone E, Fiers W, Haegeman G . (1997). Mol Cell Biol 17: 3733–3743.

  • Prives C . (1998). Cell 95: 5–8.

  • Raman V, Martensen SA, Reisman D, Evron E, Odenwald WF, Jaffee E et al. (2000). Nature 405: 974–978.

  • Reed JC, Alpers JD, Nowell PC, Hoover RG . (1986). Proc Nat Acad Sci USA 83: 3982–3986.

  • Reich NC, Levine AJ . (1984). Nature 308: 99–201.

  • Reisman D, Eaton E, McMillin D, Doudican NA, Boggs K . (2001). Gene 274: 129–137.

  • Reisman D, Loging WT . (1998). Sen Cancer Biol 8: 317–324.

  • Reisman D, Rotter V . (1993). Nucleic Acids Res 21: 345–350.

  • Reisman D, Elkind B, Roy B, Beamon J, Rotter V . (1993). Cell Growth Differ 4: 57–65.

  • Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A et al. (1998). GenesDev 12: 2831–2841.

  • Sealy L, Bundy LM . (2003). Oncogene 22: 869–883.

  • Sigal A, Rotter V . (2000). Cancer Res 60: 6788–6793.

  • Stommel JM, Marchenko ND, Jiminiz GS, Moll UM, Hope TJ, Wahl GM . (1999). EMBO J 18: 1660–1672.

  • Stuart ET, Haffner R, Oren M, Gruss P . (1995). EMBO J 14: 5638–5645.

  • Vales LV, Friedl EM . (2002). J Biol Chem 211: 42438–42446.

  • Vogelstein B, Lane D, Levine AJ . (2000). Nature 408: 307–310.

  • Vousden KH, Lu X . (2002). Nat Rev 2: 594–604.

  • Wu H, Lozano G . (1994). J Biol Chem 269: 20067–20074.

  • Zhang Y, Xiong Y . (2001). Science 292: 1910–1915.

  • Zhao R, Gish K, Murphy M, Yin Y, Notterman D, Hoffman WH et al. (2000). Genes Dev 14: 981–993.

Download references

Acknowledgements

We thank K Miskimins (University of South Dakota) for providing the Swiss3T3 cells used in this study. We also thank M Dewey for critical reading of the manuscript. This work was supported in part by grants from the American Cancer Society (RPG-98-198-01), Elsa U Pardee Foundation and National Institutes of Health (BRIN P20 RR16461). KB was funded by the Department of Defense Breast Cancer Predoctoral Traineeship Award (DAMD17-02-1-0565).

Author information

Authors and Affiliations

  1. Department of Biological Sciences, University of South Carolina, Columbia, SC, USA

    K Boggs & D Reisman

Authors
  1. K Boggs
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D Reisman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D Reisman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boggs, K., Reisman, D. Increased p53 transcription prior to DNA synthesis is regulated through a novel regulatory element within the p53 promoter. Oncogene 25, 555–565 (2006). https://doi.org/10.1038/sj.onc.1209076

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209076

Keywords

This article is cited by

Search

Advanced search

Quick links